Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ZL-1218 |
Trade Name | |
Synonyms | ZL 1218|ZL1218 |
Drug Descriptions |
ZL-1218 is an anti-CCR8 antibody, which potentially induces antibody-dependent cellular cytotoxicity against CCR8-expressing T-regulatory cells and inhibition of tumor growth (Cancer Res (2022) 82 (12_Supplement): 3590). |
DrugClasses | CCR8 Antibody 9 |
CAS Registry Number | NA |
NCIT ID | C200059 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Pembrolizumab + ZL-1218 | Pembrolizumab ZL-1218 | 0 | 1 |
ZL-1218 | ZL-1218 | 0 | 1 |